U.K.-based drug giant AstraZeneca announced Jan. 13 it would be halting its Phase III trial of Epanova, a medication comprised of omega-3 carboxylic acids, early due to disappointing data.

The future of diabetes diagnosis and management could lie in a “smart” LED contact lens, a study published in Nature Reviews Materials suggests.

A group of scientists from the University of Alabama at Birmingham have derived predictive equations to identify adults at a high risk of having nocturnal hypertension or nondipping systolic blood pressure—both hard-to-catch conditions that can raise a person’s risk for CVD.

Blood pressure-monitoring technology is hitting the wearables market hard this year, and tech companies are vying to create the optimal tool for tracking BP on the go. But one company thinks they already have it figured out, according to CNET—in the form of BP-monitoring earbuds.

Taking steps to keep older patients’ systolic blood pressure under the 120 mmHg mark could lower those patients’ risk of MI, stroke, death and mild cognitive impairment, according to a new study—but it could also fast-track a decline in kidney health.

Working long hours was linked to as much as a 70% increased risk of masked hypertension and a 66% greater risk of sustained hypertension in a recent study of 3,500 white-collar employees in Quebec, Canada.

Research led by a team at the University of Kentucky and funded by the American Heart Association and National Institutes of Health has uncovered a new biomarker for cardiovascular disease: an apolipoprotein/antibody combo.

Switching to a healthier diet could save Americans more than $300 annually and could cut U.S. healthcare costs by $50 billion, a new study suggests.